RECENT MEDICAL JOURNAL ARTICLES THAT ARE AVAILABLE AT NO COST

>>  "Retrospective Multicenter Analysis of Real-Life Toxicity and Outcome of Ipilimumab and Nivolumab in Metastatic Uveal Melanoma" (Original Research)

Authors: Ciernik, Ciernik, Bonczkowitz, et al. The Oncologist, July 2025.

>>  "Long-Term Non-Conditional and Conditional Metastasis of Uveal Melanoma by Tumor Size Category in 8034 Patients" (Original Research)

Authors: Bansai, Sener, Shields, et al. Indian Journal of Ophthalmology, May 2025.

>>  "BAP1 Loss Affords Lipotoxicity Resistance in Uveal Melanoma" (Original Research)

Authors: Cunanan, Amirfallah, Sanders, et al. Pigment Cell & Melanoma Research, May 2025.

>>  "Early Treatment in Patients With Small and Medium-Small Class 2 Gene Expression Profiling Uveal Melanoma to Reduce Mortality" (Original Research)

Authors: González, Villegas, Gold, et al. Journal of VitreoRetinal Diseases, April 2025.

>>  "An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma" (Original Research)

Authors: Zager, Marloff, Ferrucci, et al. Annals of Surgical Oncology, April 2025.

>>  "Optimizing TIL [Tumor Infiltrating Lymphocytes] Therapy for Uveal Melanoma: Lessons Learned and Unlearned from Cutaneous Melanoma" (Review)

Authors: Leonard-Murali and Kammula. Immunotherapy, March 2025.

>>  "BAP1 Tumor Predisposition Syndrome" (Review)

Authors: Pilarski, Byrne, Carlo, et al. GeneReviews, December 2024.

>>  "Proton Therapy in Uveal Melanoma" (Review)

Authors: Chan, Lin, Yacoub, et al. Cancers, October 2024.

>>  "Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma" (Review)

Authors: Varela, Villatoro, Lorenzo, et al. Cancers, September 2024.

>>  "Long-Term Survival Follow-Up for Tebentafusp in Previously Treated Metastatic Uveal Melanoma" (Original Research)

Authors: Sacco, Carvajal, Butler, et al. Journal for ImmunoTherapy of Cancer, June 2024. 

>>  "Current and Emerging Radiotherapy Options for Uveal Melanoma" (Review)

Authors: Semeniuk, Yu, and Rivard. Cancers, March 2024.

>>  "From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma" (Review)

Authors: Synoradzki, Paduszyńska, Solnik, et al. Current Oncology, February 2024.

>>  "Surveillance for Metastasis in High-Risk Uveal Melanoma Patients: Standard Versus Enhanced Protocols" (Original Research)

Authors: Yesiltas, Zabor, Wrenn, et al. Cancers, October 2023.

>>  "Emerging Techniques in the Treatment of Conjunctival Melanoma" (Review)

Authors: Li, Venkateswaran, Antonietti, et al. Current Ophthalmology Reports, June 2025.

>>  "Conjunctival Melanoma: A Narrative Review of Current Knowledge" (Review)

Authors: Papaoikonomou, Pavlidis, Apalla, et al. Pigment Cell & Melanoma Research, March 2025.

>>  "Metastatic Conjunctival Melanoma: A Multicentre International Study" (Original Research)

Authors: Jain, Finger, Filì, et al. British Journal of Ophthalmology, December 2024.

>>  "Epigenetics of Conjunctival Melanoma: Current Knowledge and

Future Directions" (Review)

Authors: Flick, Demirci, and Demirci. Cancers, October 2024.

>>  "Conjunctival Melanoma: A Clinical Review and Update" (Review)

Authors: Butt, Hussain, Coupland, et al. Cancers, September 2024.

>>  "Artificial Intelligence and Machine Learning a New Frontier in the Diagnosis of Ocular Adnexal Tumors: A Review" (Review)

Authors: Qurban and Cassidy. Sage Open Medicine, August 2024.

>>  "Pediatric Conjunctival Melanoma: A Comprehensive Case Report and Literature Review" (Case Report and Review)

Authors: Cantu-Soriano, Sanchez, Suarez-Reynoso, et al. American Journal of Ophthalmology Case Reports, May 2024.

>>  "Conjunctival Nevus" (Review)

Authors: Huang, Locatelli, Chocron, et al. Current Ophthalmology Reports, December 2023.

>>  "A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance" (Original Research)

Authors: Mudhar, Krishna, Cross, et al. Laboratory Investigation, November 2023.